Advertisement
David Willman

David Willman is a reporter for the Los Angeles Times based in Washington, D.C. Willman won the Pulitzer Prize for investigative reporting for articles that prompted the market withdrawal of Rezulin, a widely sold diabetes drug. His subsequent reports, documenting widespread pharmaceutical industry payments to federal researchers, triggered a ban of such compensation at the U.S. National Institutes of Health. His work has also exposed the nation’s unreliable system for countering bioterrorism. He is author of “The Mirage Man,” the groundbreaking account of the anthrax letter attacks. Willman’s national honors include the top award from Investigative Reporters and Editors (twice), the Worth Bingham Prize for Investigative Journalism, the Scripps Howard Foundation’s award for best Washington-based reporting and, with colleagues, the George Polk Award.
Mueller decided not to subpoena Trump to avoid a lengthy court fight

In the end, Robert S. Mueller III – who was denounced ceaselessly by President Trump and his backers for supposedly waging a “witch hunt” – wound up sparing the president with what may have been his most consequential decision as the special counsel – a subpoena.

Cuestionan confiabilidad del nuevo sistema de detección de armas biológicas

Los dispositivos también fallaron en las pruebas para detectar pequeñas esporas de ántrax

Advertisement
Advertisement